Principle standards and problems regarding proof of efficacy in clinical psychopharmacology
✍ Scribed by Hans-Jürgen Möller; Karl Broich
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 334 KB
- Volume
- 260
- Category
- Article
- ISSN
- 1433-8491
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Assessing the outcome of patients with invasive pulmonary aspergillosis by using conventional criteria is difficult, particularly when clinical and radiologic worsening coincides with neutrophil recovery. Usually, it is assumed that this deterioration is related to progr
## Abstract ## Background ‘Vascular depression’ may be caused by cerebrovascular disease. Calcium channel blockers, which are putative treatments for cerebrovascular disease, might be expected to improve depression reduction and to prevent recurrence of depression in this patient population. This